While there were outliers, Marston said a major chunk of the investments are concentrated in a few key hubs: Pennsylvania and ...

Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

PharmaCloud offers DeepHow’s AI-powered platform within a validated, audit-ready cloud for regulated manufacturing.

A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...

TopGum Industries signed a binding letter of intent to acquire U.S.-based operations manufacturing pharmaceutical products ...

DeepHow today announced the General Availability of PharmaCloud, a GMP-compliant cloud environment purpose-built for pharmaceutical and medical device manufacturers to standardize operator training, ...

Industry reports the Saudi pharmaceutical CDMO market is expected to increase from USD $1.62 billion in 2024 to USD $2.24 ...

Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...

While 2025 was the year of disruption for Trump’s pharma policies, we expect 2026 to be the year of truth: will the US ...

Novartis will invest about $70M to build a Florida radioligand therapy plant, expanding its U.S. cancer drug manufacturing ...

Staying ahead of pharma supply challenges rests on anticipatory pillars and does not require reinventing the wheel, says ...

The ‘KojoX’ method of cloning facilities around the globe keeps the CDMO agile in an industry fractured by geopolitical ...